miR-595在生长期下颌前突患者血清中的表达水平

›› 2016, Vol. 7 ›› Issue (3): 140-147.

miR-595在生长期下颌前突患者血清中的表达水平

谷妍¹,赵春洋²,李琥²

1. 南京医科大学口腔疾病研究江苏省重点实验室
2. 南京医科大学附属口腔医院

收稿日期:2016-06-28 修回日期:2016-08-25 出版日期:2016-09-25 发布日期:2016-09-28
通讯作者: 李琥 E-mail:dentistlihu@aliyun.com
基金资助:
江苏高校优势学科建设工程资助项目;南京医科大学科技发展基金资助项目

Expression level of miR-595 in serum of patients with mandibular prognathism during growth period

YAN GU¹, ³

Received:2016-06-28 Revised:2016-08-25 Online:2016-09-25 Published:2016-09-28

摘要/Abstract

摘要： 目的：探讨microRNA-595（miR-595）在生长期骨性下颌前突患者血清中的表达水平及其与下颌骨生长的关系。方法：选取骨性下颌前突患者83例（替牙列23例，早期恒牙列60例）及正常对照92例（替牙列24例，早期恒牙列68例），用实时荧光定量PCR法检测两组样本血清中miR-595的表达情况，通过Target Scan软件预测它可能的靶基因，并对测量结果进行统计学分析。结果：与对照组相比，下颌前突组miR-595的表达量下调，与下颌骨的生长量呈负相关，有明显统计学差异（P＜0.01）。结论：miR-595可能通过靶基因对下颌骨生长起负调控（抑制）作用。

Abstract: Objective: To study the level of miR-595 in serum of patients with mandibular prognathism during growth period and its relationship with mandibular growth and ossification. Methods: The research chose 83 skeletal class Ⅲ malocclusion (23 mixed dentition, 60 early permanent dentition) and 92 normal controls (24 mixed dentition, 68 early permanent dentition), using RT-PCR to detect miR-595 levels in two groups and TargetScan software to predict its possible target genes. Results: Expression of miR-595 in mandibular prognathism group was down regulated. There was negative correlation between miR-595 and mandibular growth with statistical differences (P＜0.01). Conclusions: miR-595 might have inhibitory effect on mandibular growth and ossification through target gene.

中图分类号:

R783.9

谷妍赵春洋李琥. miR-595在生长期下颌前突患者血清中的表达水平[J]. , 2016, 7(3): 140-147.

YAN GU. Expression level of miR-595 in serum of patients with mandibular prognathism during growth period[J]. , 2016, 7(3): 140-147.

参考文献

[1]傅民魁.口腔正畸学[M].6版. 北京：人民卫生出版社，2014.
[2]Bartel DP.microRNAs: genomics,biogenesis,mechanism,and function[J].Cell, 2004, 116(2):281-297
[3]Lowery AJ, Miller N, McNeill RE, et al.MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management[J].Clin Cancer Res, 2008, 14(2):360-365
[4]Wu L, Belasco JG.Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs[J].Mol Cell, 2008, 29(1):1-7
[5]Mitchell PS, Parkin RK, Kroh EM, et al.Circulating microRNAs as stable blood-based markers for cancer detection[J].Proc Natl Acad Sci USA, 2008, 105(30):13-18
[6]Xie Y, Todd NW, Liu Z, et al.Altered miRNA in sputum for diagnosis of non-small cell lung cancer[J].Lung Cancer, 2010, 67(2):170-176
[7]Zhang P, Men J, Fu Y, et al.Contribution of SATB2 to the stronger osteogenic potential of bone marrow stromal cells from craniofacial bones[J].Cell Tissue Res, 2012, 350(3):425-437
[8]Hassan MQ, Gordon JA, Beloti MM, et al.A network connecting Runx2,SATB2,and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program[J].Proc Natl Acad Sci, 2010, 107(46):19879-19884
[9]Gong Y, Xu F, Zhang L, et al.MicroRNA signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells[J].Mol Cell Biochem, 2014, 387(1):227-239
[10]Gu Y, Zhang Y, Zhao C, et al.Serum microRNAs as potential biomarkers of mandibular prognathism[J].Oral Dis, 2014, 20(1):55-61
[11]Russo G, Giordano A.miRNAs: from biogenesis to networks[J].Methods Mol Biol, 2009, 563:303-352
[12]Hao Y, Zhang S, Sun S, et al.MiR-595 targeting regulation of SOX7 promoted cell proliferation of human glioblastoma[J].Biomed Pharmacother, 2016, 80:121-126
[13]Fornari F, Ferracin M, Trerè D, et al.Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC[J].PLoS One, 2015, 10(10):e0141448-
[14]Chen Y, Wang S, Zhang L, et al.Identification of ULK1 as a novel biomarker involved in miR-4487 and miR-595 regulation in neuroblastoma SH-SY5Y cell autophagy[J].Sci Rep, 2015, 5:11035-
[15]Shin JO, Lee JM, Cho KW, et al.MiR-200b is involved in Tgf-β signaling to regulate mammalian palate development[J].Histochem Cell Biol, 2012, 137(1):67-78
[16]Wei J, Shi Y, Zheng L, et al.miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2[J].J Cell Biol, 2012, 197(4):509-521
[17]Tang W, Li Y, Osimiri L, et al.Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation[J].J Biol Chem, 2011, 286(38):32995-33002
[18]Dobreva G, Chahrour M, Dautzenberg M, et al.SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation[J].Cell, 2006, 125(5):971-986